and the product purified to diastereomeric purity by column
chromatography (2 : 1 hexanes : EtOAc to 100% EtOAc) to
afford 3b (460 mg, 1.36 mmol, 82%) as a colorless, waxy solid.
The diastereomeric ratio was dete◦rmined by HPLC analysis of
crude, filtered material. Mp 91–92 C. IR 3139, 1140, 1049 cm−1.
1H NMR (300 MHz, CDCl3) d 1.11 (s, 9H), 1.16 (m, 1H), 1.41–
1.63 (m, 4H), 1.88 (m, 1H), 2.83 (d, J = 6.0, 2H), 3.16 (d, J =
7.8, 1H), 3.39 (m, 1H), 3.59 (m, 2H), 3.92 (m, 2H), 4.36 (t, J =
4.8, 1H), 7.11 (m, 5H). 13C NMR (125 MHz, CDCl3) d 22.6,
25.7, 28.8, 31.5, 42.5, 55.9, 56.9, 66.8, 101.9, 126.5, 128.3, 130.0,
137.1. HPLC (SiO2, 90 : 10 hexanes : EtOAc, 1 mL min−1):
major, 16.0 min; minor, 19.7 min, dr 88 : 12. HRMS (FAB+)
calcd for C18H30N1O3S1 [M + H] 340.194420; found 340.194641.
[a]2D5 −27.6 (c 1.06, CHCl3).
obtained. IR 2925 cm−1. 1H NMR (400 MHz, CDCl3) d 1.42 (m,
1H), 1.75–2.02 (m, 5H), 2.74 (m, 2H), 3.00 (m, 1H), 3.15 (m,
2H), 3.98 (s, br, 1H), 7.20–7.33 (m, 5H). 13C NMR (100 MHz,
CDCl3) d 24.9, 31.5, 33.6, 37.1, 46.0, 59.0, 125.9, 128.4, 128.4,
141.8. HRMS (FAB+) calcd for C12H18N [M + H] 176.144080;
found 176.143925. [a]2D5 −100.9 (c 1.00, MeOH).
From sulfinamide 3d (80 mg, 0.27 mmol), (R)-2-
isopropylpyrrolidine·HCl (5d) (20 mg, 0.13 mmol, 48%), was
obtained. IR 2964 cm−1. NMR of HCl salt of pyrrolidine
1
reported. H NMR (400 MHz, MeOD) d 1.05, (d, J = 6.8,
3H), 1.11 (d, J = 6.8, 3H), 1.72 (m, 1H), 1.95 (m, 3H), 2.05 (m,
1H), 3.19 (m, 1H), 3.34 (m, 2H). 13C NMR (100 MHz, MeOD)
d 19.1, 19.6, 23.7, 28.9, 31.0, 45.4, 67.4. HRMS (FAB+) calcd
for C7H15N [M + H] 114.128290; found 114.128275. [a]2D5 −9.20
(c 1.00, MeOH).
Pyrroline 4a. N-tert-Butanesulfinamide 3a (11 mg,
0.033 mmol) was dissolved in 95 : 5 d1TFA : D2O and the
reaction progress was monitored by 1H and 13C NMR. Complete
conversion to pyrroline 4a was observed at 15 min. Peaks
corresponding to the cleaved diol protecting group and the
tert-butanesulfinic acid are indicated separately. 1H NMR
(300 MHz, 95 : 5 d1TFA : D2O) d 2.45 (m, 1H), 3.02 (m, 1H),
3.46–3.60 (m, 2H), 5.65 (m, 1H), 7.31 (m, 2H), 7.51 (m, 3H),
9.02 (m, 1H). 13C NMR (125 MHz, 95 : 5 d1TFA : D2O) d 37.4,
59.4, 73.9, 127.6, 131.4, 132.0, 136.1, 183.4. HRMS (FAB+)
calcd for C10H12N [M + H] 146.097310; found 146.096974.
General procedure for the deprotection and reduction of 3a–3d to
afford 5a–5d
N-tert-Butanesulfinamides 3a–3d (1.0 eq.) were dissolved in
95 : 5 TFA : H2O to a final concentration of 0.1 M. After
stirring for 30 min, Et3SiH (10.0 eq.) was added to the reaction
solutions and the reaction mixtures were stirred vigorously
for 24 h. The reaction mixtures were concentrated and the
products were purified by column chromatography (20 : 1 : 0.1
to 10 : 1 : 0.5 CH2Cl2 : MeOH : NH4OH) to afford the free
amine products. After concentrating the column fractions, the
products were resuspended in MeOH and concentrated again to
ensure complete removal of all NH3. Resuspension in CH2Cl2
followed by addition of 1 M HCl in Et2O afforded the amine
hydrocholorides as yellow oils. NMRs are reported for the free
amine and purified yields and optical rotation are based on
the HCl salt of the amine products, except where indicated
otherwise.
1
1,3-Propanediol: H NMR (500 MHz, 95 : 5 d1TFA : D2O) d
2.34 (m, 2H), 4.61 (m, 4H). 13C NMR (125 MHz, 95 : 5 d1TFA :
D2O) d 29.9, 66.6. tert-Butanesulfinic acid: 1H NMR (500 MHz,
95 : 5 d1TFA : D2O) d 1.2 (s, 1H). 13C NMR (125 MHz, 95 : 5
d1TFA : D2O) d 21.5, 28.2.
Compounds 8-(R,R) and 8-(R,S). Pyrrolidine 5a (140 mg,
0.11 mmol, 0.2 M) was dissolved in THF (4.0 mL) and i-Pr2EtN
(300 lL, 1.7 mmol, 2.2 eq.) was added. The resulting solution
was added to a solution of THF (4.8 mL) containing DMAP
(23 mg, 0.19 mmol, 0.2 eq.), i-Pr2EtN (240 lL, 1.4 mmol,
1.5 eq.) and tert-butanesulfinyl chloride (0.47 mL, 2.0 M in
toluene, 0.95 mmol, 1.2 eq.). The resulting solution was stirred
at rt for 12 h. The reaction mixture was concentrated and
the products purified by column chromatography (4 : 1 to 2 :
1 hexanes : EtOAc) to afford 8-(R,R) (49 mg, 0.19 mmol,
25%) as a white solid and 8-(R,S) (100 mg, 0.40 mmol, 50%)
From sulfinamide 3a (91 mg, 0.28 mmol), (R)-2-
phenylpyrrolidine·HCl (5a) (45 mg, 0.25 mmol, 88%) was
1
obtained. IR 2957 cm−1. H NMR (500 MHz, CDCl3) d 1.70
(m, 1H), 1.83–1.95 (m, 2H), 2.18 (m, 1H), 2.77 (s, br, 1H), 3.00
(m, 1H), 3.19 (m, 1H), 4.10 (t, J = 7.5, 1H), 7.22–7.35 (m, 5H).
13C NMR (125 MHz, CDCl3) d 25.4, 33.9, 46.6, 62.6, 126.5,
127.0, 128.4, 143.4. HRMS (FAB+) calcd for C10H14N1 [M +
H] 148.112850; found 148.112625. [a]2D5 −9.10 (c 1.00, MeOH),
literature [a]D −22.0 (c 2.0, MeOH).7a
1
as a yellow oil. 8-(R,R): IR 1058 cm−1. H NMR (500 MHz,
To confirm optical purity, pyrrolidine 5a (7 mg, 0.05
mmol) was dissolved in CH2Cl2 (0.5 mL). The solution was
cooled to 0 ◦C and i-Pr2EtN (0.02 mL, 0.1 mmol) was
added to the solution, followed by either (R)-(+)-a-methoxy-
a-(trifluoromethyl)phenylacetyl chloride (MTPA) or (S)-(+)-a-
methoxy-a-(trifluoromethyl)phenylacetyl chloride (25 mg, 0.1
mmol). After stirring for 30 min at 0 ◦C, the solutions were
warmed to rt, diluted with CH2Cl2 and washed with 1.0 M
NaHSO4(aq). The organic layers were dried (Na2SO4) and con-
centrated to afford the MTPA amides. HPLC analysis (2.1 cm ×
5 lM Hypersil Si column, detection at 210 nm, 1 mL min−1,
98 : 2 hexanes : iPrOH) on the unpurified material established
≥99% enantiomeric excess, with the tR = 6.09 min for the amide
derived from the (R)-(+)-MTPA chloride and tR = 8.13 min for
the amide derived from the (S)-(−)-MTPA chloride.
CDCl3) d 1.10 (s, 9H), 1.77–1.90 (m, 3H), 2.13 (m, 1H), 3.57
(m, 1H), 3.67 (m, 1H), 5.06 (dd, J = 2.5, 8, 1H), 7.20–7.32
(m, 5H). 13C NMR (125 MHz, CDCl3) d 23.0, 24.1, 36.6, 54.9,
57.4, 88.7, 123.3, 126.3, 126.5, 144.6. HRMS (FAB+) calcd for
C14H22NOS [M + H] 252.141490; found, 252.142211. [a]2D5 +108.8
1
(1.00 c, CHCl3). 8-(R,S): IR 1060 cm−1. H NMR (300 MHz,
CDCl3) d 1.10 (s, 9H), 1.87 (m, 2H), 1.97 (m, 1H), 2.23 (m,
1H), 2.99 (m, 1H), 3.89 (m, 1H), 4.64 (m, 1H), 7.20–7.35 (m,
5H). 13C NMR (125 MHz, CDCl3) d 23.7, 26.3, 35.9, 42.0,
57.2, 69.2, 127.1, 127.1, 128.2, 143.2. HRMS (FAB+) calcd for
C14H22NOS [M + H] 252.141490; found 252.142211. [a]2D5 +93.6
(c 0.99, CHCl3).
Pyrroline 6. Et3SiH (0.46 mL, 2.8 mmol, 10 eq.) in 95 : 5 TFA :
H2O (2.8 mL) was added to sulfinamide 3a (92 mg, 0.28 mmol).
The reaction mixture was stirred overnight, concentrated and
the product purified by column chromatography (30 : 1 CH2Cl2 :
MeOH, 0.1% NH4OH). To remove traces of Et3SiH, the product
was dissolved in 1 M HCl(aq), washed with Et2O, brought to
basic pH with solid NaHCO3 and extracted with CH2Cl2. The
CH2Cl2 layer was dried (Na2SO4), acidified with 1 M HCl in
Et2O and concentrated to afford◦6 (20 mg, 14 mmol, 50%) as
From sulfinamide 3b (74 mg, 0.22 mmol), (R)-2-
benzylpyrrolidine·HCl (5b) (30 mg, 0.19 mmol, 84%) was
1
obtained. IR 2923 cm−1. H NMR (500 MHz, CDCl3) d 1.70
(m, 1H), 1.94 (m, 1H), 1.97 (m, 2H), 2.88 (m, 1H), 3.12 (m, 2H),
3.26 (m, 1H), 3.63 (m, 1H), 3.97 (s, br, 1H), 7.21 (m, 5H). 13C
NMR (125 MHz, CDCl3) d 22.7, 29.5, 37.4, 44.9, 61.9, 126.9,
128.6, 128.6, 136.6. HRMS (FAB+) calcd for C11H16N1 [M + H]
162.128140; found 162.128275. [a]2D5 −9.20 (c 1.00, MeOH), [a]2D5
−17.0 (c 1.00, 2 N HCl), literature [a]2D5 −15.1 (c 0.6, MeOH),26
for enantiomer [a]2D5 (20.00 (c 0.3, MeOH).7b
1
a glassy, clear solid. Mp 73–74 C. IR 1645 cm−1. H NMR
(500 MHz, MeOD) d 2.46 (m, 2H), 3.69 (m, 2H), 4.27 (m, 2H),
7.69 (m, 2H), 7.85 (m, 1H), 8.09 (m, 2H). 13C NMR (125 MHz,
MeOD) d 19.5, 35.1, 53.6, 125.9, 129.5, 130.2, 136.2, 186.1.
HRMS (FAB+) calcd for C10H12N1 [M + H] 146.097170; found
146.096974.
From sulfinamide 3c (84 mg, 0.24 mmol), (R)-2-
phenethylpyrrolidine·HCl (5c) (33 mg, 0.15 mmol, 63%), was
2 1 1 2
O r g . B i o m o l . C h e m . , 2 0 0 5 , 3 , 2 1 0 9 – 2 1 1 3